Long COVID-19 poses a growing and complex challenge for the headache and migraine community. For about one in five long-COVID patients, headache is among the symptoms that linger after acute COVID-19 infection subsides.
To explore the issue, The Headache & Migraine Policy Forum hosted “Long COVID and Headache Disorders,” a national policy panel discussion held both virtually and in person at the U.S. Capitol Visitor Center in Washington, DC. The Headache & Migraine Policy Forum, led by Executive Director Lindsay Videnieks, has been a catalyst for policy change. The forum coincided with the 16th annual Headache on the Hill day, sponsored by the Alliance for Headache Disorders Advocacy.
